BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen SF, Wang FM, Li ZY, Yu F, Chen M, Zhao MH. Complement Factor H Inhibits Anti-Neutrophil Cytoplasmic Autoantibody-Induced Neutrophil Activation by Interacting With Neutrophils. Front Immunol 2018;9:559. [PMID: 29616045 DOI: 10.3389/fimmu.2018.00559] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Sciascia S, Ponticelli C, Roccatello D. Pathogenesis-based new perspectives of management of ANCA-associated vasculitis. Autoimmun Rev 2021;:103030. [PMID: 34971805 DOI: 10.1016/j.autrev.2021.103030] [Reference Citation Analysis]
2 Austin K, Janagan S, Wells M, Crawshaw H, Mcadoo S, Robson JC. ANCA Associated Vasculitis Subtypes: Recent Insights and Future Perspectives. JIR 2022;Volume 15:2567-82. [DOI: 10.2147/jir.s284768] [Reference Citation Analysis]
3 Ohlsson S, Holm L, Hansson C, Ohlsson SM, Gunnarsson L, Pettersson Å, Skattum L. Neutrophils from ANCA-associated vasculitis patients show an increased capacity to activate the complement system via the alternative pathway after ANCA stimulation. PLoS One 2019;14:e0218272. [PMID: 31216309 DOI: 10.1371/journal.pone.0218272] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
4 Xu PC, Chen T, Wu SJ, Yang X, Gao S, Hu SY, Wei L, Yan TK. Pathological severity determines the renal recovery for anti-myeloperoxidase antibody-associated vasculitis requiring dialysis at disease onset: a retrospective study. BMC Nephrol 2019;20:287. [PMID: 31362703 DOI: 10.1186/s12882-019-1487-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
5 Quintana LF, Kronbichler A, Blasco M, Zhao MH, Jayne D. ANCA associated vasculitis: The journey to complement-targeted therapies. Mol Immunol 2019;112:394-8. [PMID: 31291610 DOI: 10.1016/j.molimm.2019.06.018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
6 Dijkstra DJ, Joeloemsingh JV, Bajema IM, Trouw LA. Complement activation and regulation in rheumatic disease. Seminars in Immunology 2019;45:101339. [DOI: 10.1016/j.smim.2019.101339] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
7 Wester Trejo MAC, Trouw LA, Bajema IM. The role of complement in antineutrophil cytoplasmic antibody-associated vasculitis. Curr Opin Rheumatol 2019;31:3-8. [PMID: 30461541 DOI: 10.1097/BOR.0000000000000557] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Jayne D. Complement inhibition in ANCA vasculitis. Nephrol Ther 2019;15:409-12. [PMID: 31631015 DOI: 10.1016/j.nephro.2019.04.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
9 Li W, Zhang Q, Xie L, Fan N, Liu Z, Zhang L, Zhang J, Tang S, Wang W, Liu X, Li X, Wang H, Zhao J, Huang Y, Zhang J. Clinical significance and role of CXCL16 in anti-neutrophil cytoplasmic autoantibody-associated vasculitis. Immunol Lett 2022:S0165-2478(22)00011-6. [PMID: 35120907 DOI: 10.1016/j.imlet.2022.01.003] [Reference Citation Analysis]
10 Kárpáti É, Kremlitzka M, Sándor N, Hajnal D, Schneider AE, Józsi M. Complement Factor H Family Proteins Modulate Monocyte and Neutrophil Granulocyte Functions. Front Immunol 2021;12:660852. [PMID: 34671340 DOI: 10.3389/fimmu.2021.660852] [Reference Citation Analysis]
11 Sun Q, Li N, Jia L, Guo W, Jiang H, Liu B, Bao C, Liu M, Huang J, Lei L. Ribosomal Protein SA-Positive Neutrophil Elicits Stronger Phagocytosis and Neutrophil Extracellular Trap Formation and Subdues Pro-Inflammatory Cytokine Secretion Against Streptococcus suis Serotype 2 Infection. Front Immunol 2020;11:585399. [PMID: 33603733 DOI: 10.3389/fimmu.2020.585399] [Reference Citation Analysis]
12 Massicotte-azarniouch D, Herrera CA, Jennette JC, Falk RJ, Free ME. Mechanisms of vascular damage in ANCA vasculitis. Semin Immunopathol. [DOI: 10.1007/s00281-022-00920-0] [Reference Citation Analysis]
13 Wang LY, Sun XJ, Wang C, Chen SF, Li ZY, Chen M, Little MA, Zhao MH. Sphingosine-1-phosphate receptor modulator FTY720 attenuates experimental myeloperoxidase-ANCA vasculitis in a T cell-dependent manner. Clin Sci (Lond) 2020;134:1475-89. [PMID: 32538435 DOI: 10.1042/CS20200497] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Tsiakas S, Marinaki S, Lionaki S, Boletis J. Plasma Exchange in ANCA-Associated Vasculitis: A Narrative Review. J Clin Med 2021;10:5154. [PMID: 34768675 DOI: 10.3390/jcm10215154] [Reference Citation Analysis]